By

Hudaa Croeser
Research Article Abstract Introduction: Preventive therapy is essential for reducing tuberculosis (TB) burden among people living with HIV (PLWH) in high-burden settings. Short-course preventive therapy regimens, such as three-month weekly rifapentine and isoniazid (3HP) and one-month daily rifapentine and isoniazid (1HP), may help facilitate uptake of preventive therapy for latently infected patients, but the comparative...
Read More
The aim of the target product profiles (TPPs) for TPT is to identify the product attributes to be considered in developing the best, most suitable TB prevention treatments. These TPPs are expected to assist developers in aligning the characteristics of new treatment regimens and developers’ performance and operational targets with national requirements. This document describes...
Read More
1 3 4 5 6 7 9